| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0168-8227(95)01076-P |
| P8608 | Fatcat ID | release_6mz3oahhujemjf4wwfldziftua |
| P698 | PubMed publication ID | 8529521 |
| P50 | author | Günter Müller | Q42676778 |
| P2093 | author name string | W Kramer | |
| F Girbig | |||
| U Gutjahr | |||
| S Kowalewski | |||
| D Hartz | |||
| H D Summ | |||
| P2860 | cites work | Cloning and functional expression of a rat heart KATP channel | Q28245885 |
| P921 | main subject | molecular interaction | Q33059490 |
| P304 | page(s) | S67-80 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | Diabetes Research and Clinical Practice | Q15750054 |
| P1476 | title | The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels | |
| P478 | volume | 28 Suppl |
| Q94054456 | Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes |
| Q57504439 | Characterization of sulfonylurea receptors in isolated human pancreatic islets |
| Q38147723 | Clinical relevance of target identity and biology: implications for drug discovery and development |
| Q33903076 | Comparative tolerability of sulphonylureas in diabetes mellitus |
| Q35533439 | Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals |
| Q37279993 | Glibenclamide for the treatment of acute CNS injury |
| Q35380697 | Glibenclamide for the treatment of ischemic and hemorrhagic stroke |
| Q36899187 | Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus |
| Q34548647 | The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents |
| Q34903312 | Transcriptomic analysis of insulin-sensitive tissues from anti-diabetic drug treated ZDF rats, a T2DM animal model |
| Q78236765 | [Present status in the treatment of type 2 diabetes mellitus. Insulin-secreting agents] |
Search more.